{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} FDA Proposes Extended-Release Hydrocodone as Schedule II Drug
Activity Steps
{{ evaluation.question.text }}
{{choice.text}}
{{evaluation.answerSet[0].text}}
Description
This article discusses how the overuse and overprescribing of opioid analgesics is a continuing issue in medicine. Addiction to and morbidity from prescription opioids have skyrocketed. A number of government agencies have tried to limit prescribing and to close pain centers dedicated to providing opioids to anyone who walks in the door, however, these actions have not solved the burgeoning problem. This article reviews the current role of hydrocodone and puts the potential advantages and disadvantages of the recently approved long-acting hydrocodone preparation into perspective. Method of Participation in the Learning Process/Evaluation Method Successful completion of this activity includes reading the entire article and successfully completing the post-quiz and an evaluation form. Getting the Most out of the Activity As you prepare to participate in this activity, please reflect on your practice and your patients and identify clinical challenges you hope to have addressed. While participating in the training, identify ways you can use newly acquired knowledge, strategies, and skills to enhance patient outcomes and your own professional development.Purpose of Activity
To provide information about the use of opioid analgesics, specifically, its advantages and disadvantages, the potential for overdose, and how to treat those who have overdosed in the ED.Learning Objectives
After completing this continuing education activity you will be able to:
- Classify the benefits and disadvantages of extended-release hydrocodone.
- Assess the potential for overdose.
- Prepare a plan for treating these patients in the emergency department.
Disclosures
All faculty members and all LCMEI staff members in a position to control the content of this CME activity have disclosed that they and their spouse/life partners (if any) have no financial relationships with, or financial interests in, any commercial companies pertaining to this educational activity.
Price:
$10.00
Credits:
- ACCME 1.0 CME
Lippincott Continuing Medical Education Institute, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.Lippincott Continuing Medical Education Institute, Inc. designates this enduring material for a maximum of 1.0 AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
{{ evaluation.question.text }}
{{choice.text}}
{{evaluation.answerSet[0].text}}
Professions:
Physician
Test Code: EMN0514
Published: May 2014
Expires: 1/1/2026
Sources:
Emergency Medicine News
Required Passing Score: 7/10 (70%)
Categories:
Emergency Care
,
Substance Use/Abuse
Specialties:
Emergency Medicine